Patents by Inventor Dawid Grzegorz Nowak

Dawid Grzegorz Nowak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9447418
    Abstract: The invention provides a method of selectively pro-oranti-angiogenic treatment of a mammalian subject, comprising site-specific control of alternative splicing during processing of VEGF pre-mRNA transcribed from the C terminal exon 8 of the VEGF gene using controlling agents for the splicing, wherein one or more controlling agent which favors proximal splice site (PSS) splicing in said processing is used in the pro-angiogenic treatment and one or more controlling agent which favors distal splice site (DSS) splicing in said processing is used in the anti-angiogenic treatment.
    Type: Grant
    Filed: March 10, 2008
    Date of Patent: September 20, 2016
    Assignee: UNIVERSITY OF BRISTOL
    Inventors: David Bates, Steven James Harper, Dawid Grzegorz Nowak
  • Publication number: 20100210527
    Abstract: The invention provides a method of selectively pro-oranti-angiogenic treatment of a mammalian subject, comprising site-specific control of alternative splicing during processing of VEGF pre-mRNA transcribed from the C terminal exon 8 of the VEGF gene using controlling agents for the splicing, wherein one or more controlling agent which favours proximal splice site (PSS) splicing in said processing is used in the pro-angiogenic treatment and one or more controlling agent which favours distal splice site (DSS) splicing in said processing is used in the anti-angiogenic treatment.
    Type: Application
    Filed: March 10, 2008
    Publication date: August 19, 2010
    Applicant: UNIVERSITY OF BRISTOL
    Inventors: David Bates, Steven James Harper, Dawid Grzegorz Nowak